https://www.moneycontrol.com/news/business/markets/glenmark-launches-biosimilar-of-anti-diabetic-drug-vows-to-cut-down-therapy-cost-by-70-11991461.html
0
0
1/3/24 at 4:50am
Organization
Moneycontrol
Author
Neethi Rojan
Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent
Create an account
or login to join the discussion